Evotec agrees sale of France plant to Sandoz, shares rise

Sandoz AG

30/07/2025 08:33

** Shares in Evotec EVTG.DE are up 3.2% after the German biotech company signed an agreement with Sandoz SDZ.S to sell the Just – Evotec Biologics site in Toulouse, France

** The deal terms include the purchase price of the site for around $300 million in cash

** "The transaction should have a positive impact on Evotec's near- and long-term revenue mix, profit margins and return on capital," RBC says

** Van Lanschot Kempen says the agreement should be another industry validation of the Just Biologics' continuous manufacturing business, which the broker sees as the key value driver for the investment thesis

 (Reporting by Bartosz Dabrowski in Gdansk)

 ((bartosz.dabrowski@thomsonreuters.com; +48 58 7696560;))